RB's Health sales hit by Scholl and cyberattack

25 July 2017 - Deborah Wilkes

Sales at RB's Health division were down by 4% on a like-for-like basis in the second quarter of 2017. The company said declines for Scholl/Amopé footcare products had continued to have an impact, and "cyberattack issues" at the very end of the quarter had contributed to the fall.